SCHEMBL23316707

SCHEMBL23316707

COC(=O)CCc1ccc2c(c1)nc(Nc1ccc(OC(F)(F)F)cc1)n2C(C)c1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23316706 1.00 IDH1 (0.61) IDH1
SCHEMBL23316428 0.94 IDH1 (0.59) IDH1
SCHEMBL23316431 0.94 IDH1 (0.59) IDH1
SCHEMBL23316448 0.93 IDH1 (0.61) IDH1
SCHEMBL23316558 0.93 IDH1 (0.61) IDH1
SCHEMBL23316449 0.93 IDH1 (0.61) IDH1
SCHEMBL23316599 0.93 IDH1 (0.60) IDH1
SCHEMBL23621921 0.93 IDH1 (0.60) IDH1
SCHEMBL23316598 0.93 IDH1 (0.60) IDH1
SCHEMBL26655819 0.93 IDH1 (0.53) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3816158-B1 BENZIMIDAZOLE DERIVATIVES AND USE THEREOF AS IDH1 INHIBITORS KPC PHARMACEUTICALS INC (CN) 2023-10-25 EP disclosed
EP-3816158-A1 BENZIMIDAZOLE DERIVATIVES AND USE THEREOF AS IDH1 INHIBITORS KPC Pharmaceuticals, Inc. (CN) 2021-05-05 EP disclosed